Table 2.
The cancer genome atlas (TCGA) samples
| Cohort | Description | mRNA tumor | mRNA NT | DEA | N CNVs |
|---|---|---|---|---|---|
| ACC | Adrenocortical carcinoma | 79 | 0 | NP | 89 |
| BLCA | Bladder Urothelial Carcinoma | 408 | 19 | OK | 406 |
| BRCA | Breast invasive carcinoma | 1093 | 112 | OK | 996 |
| CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma | 304 | 3 | LN | 278 |
| CHOL | Cholangiocarcinoma | 36 | 9 | OK | 36 |
| COADREAD | Colorectal adenocarcinoma | 379 | 51 | OK | 526 |
| DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | 48 | 0 | NP | 37 |
| ESCA | Esophageal carcinoma | 184 | 11 | OK | 182 |
| GBM | Glioblastoma multiforme | 153 | 5 | LN | 378 |
| HNSC | Head and Neck squamous cell carcinoma | 520 | 44 | OK | 496 |
| KICH | Kidney Chromophobe | 66 | 25 | OK | 65 |
| KIRC | Kidney renal clear cell carcinoma | 533 | 72 | OK | 354 |
| KIRP | Kidney renal papillary cell carcinoma | 290 | 32 | OK | 274 |
| LAML | Acute Myeloid Leukemia | 0 | 0 | NP | 109 |
| LGG | Brain Lower Grade Glioma | 516 | 0 | NP | 507 |
| LIHC | Liver hepatocellular carcinoma | 371 | 50 | OK | 353 |
| LUAD | Lung adenocarcinoma | 515 | 59 | OK | 507 |
| LUSC | Lung squamous cell carcinoma | 501 | 51 | OK | 649 |
| MESO | Mesothelioma | 87 | 0 | NP | 82 |
| OV | Ovarian serous cystadenocarcinoma | 302 | 0 | NP | 398 |
| PAAD | Pancreatic adenocarcinoma | 178 | 4 | LN | 175 |
| PCPG | Pheochromocytoma and Paraganglioma | 179 | 3 | LN | 692 |
| PRAD | Prostate adenocarcinoma | 497 | 52 | OK | 488 |
| SARC | Sarcoma | 259 | 2 | NP | 232 |
| SKCM | Skin Cutaneous Melanoma | 103 | 1 | NP | 363 |
| STAD | Stomach adenocarcinoma | 415 | 35 | OK | 434 |
| STES | Stomach and Esophageal carcinoma | 599 | 46 | OK | 265 |
| TGCT | Testicular Germ Cell Tumors | 150 | 0 | NP | 144 |
| THCA | Thyroid carcinoma | 501 | 59 | OK | 482 |
| THYM | Thymoma | 120 | 2 | NP | 123 |
| UCEC | Uterine Corpus Endometrial Carcinoma | 176 | 24 | OK | 509 |
| UCS | Uterine Carcinosarcoma | 57 | 0 | NP | 56 |
| UVM | Uveal Melanoma | 80 | 0 | NP | 80 |
NT, Normal Tissue; DEA, Differential Expression Analysis; NP, Not Possible; LN, Low Number; N, Number of samples available; CNV, Copy Number Variation; OK, Possible.